Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Government of Canada was posted on June 12, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Supply of Ultra-High-Performance Liquid Chromatography System (UHPLC-DAD-FLD)

Closed
International

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The contract involves the supply, delivery, and basic installation support of an Ultra-High-Performance Liquid Chromatography system equipped with Diode Array Detection and Fluorescence Detection (UHPLC-DAD-FLD) for analytical testing purposes at the Health Canada Products Laboratory. This procurement is managed by the Department of Health under the Government of Canada. The acquisition aims to enhance the laboratory's analytical capabilities, ensuring more precise and efficient testing. The solicitation was posted on June 12, 2026, with a response deadline set for July 2, 2026. It is categorized as a subcontract under NAICS code 334516, which pertains to analytical laboratory instrument manufacturing. The place of performance is within Canada, but specific location details or contact points are not provided. The contract supports the government’s efforts to maintain high standards in health product testing through updated and advanced instrumentation.

General Info

Supply, delivery, and installation of UHPLC-DAD-FLD system for Health Canada analytical testing.

Agency

Government of Canada → Department of HealthView Agency

NAICS

334516 - Analytical Laboratory Instrument ManufacturingView NAICS

Place of Performance

Canada, CAN

Set-Aside

NONE

Documents

This scope was carved out of 1000272585.

The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Ultra high-performance liquid chromatography system with diode array and fluorescence detection

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyGovernment of Canada → Department of Health
ContactsNo contacts available
OfficeN/A
Organization / Agency
Government of Canada → Department of Health
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supply, delivery, and basic installation support for a new UHPLC-DAD-FLD system for analytical testing at the Health Canada Products Laboratory.

More opportunities from Government of Canada → Department of Health

Same awarding agency

NAICS: 541715
International
Request For Proposal (RFP) for Pharmacological testing of novel opioids, stimulants, and synthetic cannabinoids.
Solicitation # 1000273405
Health Canada is seeking proposals under solicitation 1000273405 to conduct in vitro pharmacological testing of novel psychoactive substances to support regulatory science and risk assessments regarding the illegal drug supply. The procurement is divided into three separate streams: Stream 1 focuses on emerging opioids at the Mu Opioid Receptor, Stream 2 addresses novel synthetic cannabinoids targeting CB1 and CB2 receptors, and Stream 3 evaluates stimulant compounds, specifically dopamine and VMAT2 uptake. Bidders may submit proposals for a single stream, two streams, or all three, with the possibility of up to three contracts being awarded. The selected contractors will be responsible for acquiring reference standards and control samples, obtaining necessary licenses for controlled substances, and performing rigorous laboratory experiments including assay validation and pharmacodynamic testing. Key deliverables include the measurement of metrics such as Ki, Emax, and EC50, followed by statistical analysis and the submission of draft and final reports. Timelines for completion vary by stream, with some activities extending up to 17.5 months from the date of the contract award. Technical and financial offers must be submitted separately for each stream by the deadline of September 18, 2026.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

12 days ago

DEADLINE

in 6 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS